Sept. 30 (Bloomberg) -- Omega Pharma NV said it spent 26.9 million euros buying back an additional 779,106 own shares in on- and off-market transactions in the period from Sept. 22 through Sept. 30, according to an e-mailed statement.

Omega Pharma, which is subject to a 36 euros-a-share buyout offer from Couckinvest NV, now holds 13.2 percent of its outstanding share count, according to the statement,

To contact the editor responsible for this story: John Martens at jmartens1@bloomberg.net